Cargando…
Protein Folding Interdiction Strategy for Therapeutic Drug Development in Viral Diseases: Ebola VP40 and Influenza A M1
In a recent paper, we proposed the folding interdiction target region (FITR) strategy for therapeutic drug design in SARS-CoV-2. This paper expands the application of the FITR strategy by proposing therapeutic drug design approaches against Ebola virus disease and influenza A. We predict target regi...
Autores principales: | Bergasa-Caceres, Fernando, Rabitz, Herschel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998936/ https://www.ncbi.nlm.nih.gov/pubmed/35409264 http://dx.doi.org/10.3390/ijms23073906 |
Ejemplares similares
-
Interdiction in the Early Folding of the p53 DNA-Binding Domain Leads to Its Amyloid-Like Misfolding
por: Bergasa-Caceres, Fernando, et al.
Publicado: (2022) -
Identification of Two Early Folding Stage Prion Non-Local Contacts Suggested to Serve as Key Steps in Directing the Final Fold to Be Either Native or Pathogenic
por: Bergasa-Caceres, Fernando, et al.
Publicado: (2021) -
Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40
por: Mirza, Muhammad Usman, et al.
Publicado: (2016) -
Demande en Interdiction
Publicado: (1848) -
Membrane binding and bending in Ebola VP40 assembly and egress
por: Stahelin, Robert V.
Publicado: (2014)